Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in NEO — Neogenomics Inc

CIK 72971 SAN FRANCISCO, CA
Back to NEO Full portfolio

Position in NEO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,860,397
+$3,264,683 QoQ
Shares Held
264,592
+229.6% QoQ
Ownership
0.206%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NEO Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $2,228,724,937 across 35 Diagnostics & Research names. NEO ranks #22 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 1,458,431 $731,198,964
2 DHR
Danaher Corp /De/
 2,107,482 $401,433,168
3 DGX
Quest Diagnostics Inc
 1,751,220 $371,171,075
4 NTRA
Natera, Inc.
 502,818 $136,489,944
5 IDXX
Idexx Laboratories Inc /De
 209,092 $110,074,391
6 LH
Labcorp Holdings Inc.
 347,544 $97,312,320
7 WAT
Waters Corp /De/
 168,498 $63,193,487
8 A
Agilent Technologies, Inc.
 462,412 $61,422,185

All Filings in NEO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,860,397 264,592
2026-03-31 $595,714 80,285
2025-12-31 $1,863,324 158,446
2025-09-30 $861,188 111,553
2025-06-30 $695,055 95,083
2025-03-31 $766,439 80,763
2024-12-31 $1,390,763 84,391
2024-09-30 $1,155,454 78,336
2024-06-30 $1,065,090 76,791
2024-03-31 $1,158,216 73,678
2023-12-31 $929,668 57,458
2023-09-30 $831,797 67,626
2023-06-30 $1,160,750 72,231
2023-03-31 $763,966 43,881
2022-12-31 $174,699 18,907
2022-09-30 $192,964 22,412
2022-06-30 $276,935 33,980
2022-03-31 $1,237,793 101,876
2021-12-31 $7,979,676 233,871
2021-09-30 $39,646,234 821,854
2021-06-30 $35,469,243 785,239
2021-03-31 $41,902,559 868,807
2020-12-31 $50,501,917 938,000
2020-09-30 $35,304,834 957,030
2020-06-30 $27,791,226 897,070
2020-03-31 $26,747,655 968,767